NeurogesX Inc.
This article was originally published in Start Up
Executive Summary
By initially focusing on compounds and targets for which some efficacy and safety data is already available, two year-old NeurogesX has already managed to produce three clinical candidates for treating pain. The most advanced is a transdermal capsaicin-based patch for treating neuropathic pain.